HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kaushik K Misra Selected Research

N- ((2- cyclopropoxy- 5- (5- trifluomethyl)tetrazol- 1- yl)benzyl)- 2- phenylpiperidin- 3- amine

5/2013The NK1 receptor antagonist L822429 reduces heroin reinforcement.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kaushik K Misra Research Topics

Disease

3Heroin Dependence (Heroin Abuse)
03/2015 - 07/2011
2Hypersensitivity (Allergy)
05/2013 - 02/2012
1Opioid-Related Disorders (Opiate Addiction)
08/2012
1Cocaine-Related Disorders (Cocaine Addiction)
08/2012
1Substance-Related Disorders (Drug Abuse)
02/2012
1Pain (Aches)
02/2012

Drug/Important Bio-Agent (IBA)

4Heroin (Diamorphine)IBA
03/2015 - 07/2011
2VaccinesIBA
12/2011 - 07/2011
1N- ((2- cyclopropoxy- 5- (5- trifluomethyl)tetrazol- 1- yl)benzyl)- 2- phenylpiperidin- 3- amineIBA
05/2013
1Narcotic Antagonists (Opioid Antagonists)IBA
08/2012
1Opioid Analgesics (Opioids)IBA
08/2012
1Buprenorphine (Subutex)FDA LinkGeneric
08/2012
1Cocaine (Cocaine HCl)IBA
08/2012
1Naltrexone (ReVia)FDA LinkGeneric
08/2012
1Opioid Receptors (Opioid Receptor)IBA
08/2012
1Opiate AlkaloidsIBA
02/2012
1Corticotropin-Releasing HormoneIBA
02/2012
1Ethanol (Ethyl Alcohol)IBA
02/2012
1Pharmaceutical PreparationsIBA
02/2012
1Immunoconjugates (Immunoconjugate)IBA
12/2011

Therapy/Procedure

2Self Administration (Administration, Self)
03/2015 - 08/2012
2Therapeutics
12/2011 - 07/2011